Compare Stocks → Special FREE offer on stock hotsheets (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CARANYSE:GNKTSE:MTY Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCARACara Therapeutics$0.67-3.5%$0.82$0.50▼$4.67$36.40M0.7661,817 shs229,150 shsGNKGenco Shipping & Trading$20.40+0.6%$19.88$12.39▼$21.24$872.10M1.18725,882 shs201,945 shsMTYMTY Food GroupC$46.31-0.6%C$51.03C$44.48▼C$68.60C$1.12B1.9850,646 shs20,081 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCARACara Therapeutics-5.72%-14.88%-22.47%+22.12%-83.57%GNKGenco Shipping & Trading+0.15%-3.10%+1.35%+18.59%+25.32%MTYMTY Food Group-0.38%-7.04%-10.78%-14.63%-23.14%2024's Must-Have Guide: Master Crypto Investment Today (Ad)The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)Click here to download your crypto reportMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCARACara Therapeutics3.931 of 5 stars3.42.00.04.22.01.71.3GNKGenco Shipping & Trading2.3947 of 5 stars1.35.02.50.01.01.72.5MTYMTY Food Group2.8919 of 5 stars3.20.01.70.01.60.82.5Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCARACara Therapeutics2.75Moderate Buy$9.751,364.18% UpsideGNKGenco Shipping & Trading2.67Moderate Buy$20.671.31% UpsideMTYMTY Food Group2.43HoldC$54.2917.22% UpsideCurrent Analyst RatingsLatest SSPG, DOM, MTY, GNK, and CARA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/19/2024GNKGenco Shipping & TradingStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $23.004/16/2024MTYMTY Food GroupRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetC$60.00 ➝ C$55.004/15/2024MTYMTY Food GroupAcumen CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuyC$75.00 ➝ C$65.004/15/2024MTYMTY Food GroupRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector PerformC$58.00 ➝ C$51.004/15/2024MTYMTY Food GroupScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector PerformC$55.00 ➝ C$50.004/15/2024MTYMTY Food GroupCIBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperformC$62.00 ➝ C$53.004/15/2024MTYMTY Food GroupTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHoldC$59.00 ➝ C$49.004/15/2024MTYMTY Food GroupNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperformC$59.00 ➝ C$57.004/10/2024CARACara TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.003/28/2024CARACara TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.003/6/2024CARACara TherapeuticsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $10.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCARACara Therapeutics$20.97M1.74N/AN/A$1.05 per share0.63GNKGenco Shipping & Trading$383.83M2.27$2.43 per share8.40$21.50 per share0.95MTYMTY Food GroupC$1.16B0.96C$1.75 per share26.52C$33.45 per share1.38Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCARACara Therapeutics-$118.51M-$2.18N/AN/AN/A-565.21%-122.10%-89.64%5/20/2024 (Estimated)GNKGenco Shipping & Trading-$12.87M-$0.31N/A8.57N/A-3.35%3.10%2.56%5/8/2024 (Confirmed)MTYMTY Food GroupC$103MC$4.2510.90∞0.758.86%13.23%4.15%7/9/2024 (Estimated)Latest SSPG, DOM, MTY, GNK, and CARA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2024N/AGNKGenco Shipping & Trading$0.43N/A-$0.43N/AN/AN/A 4/12/2024Q1 2024MTYMTY Food GroupC$0.83C$0.71-C$0.12C$0.71C$263.20 millionC$278.64 million3/4/202412/31/2023CARACara Therapeutics-$0.57-$0.59-$0.02-$0.59$2.34 million$3.00 million 2/21/2024Q4 2023GNKGenco Shipping & Trading$0.37$0.43+$0.06$0.75$72.54 million$115.50 million 2/15/2024Q4 2023MTYMTY Food GroupC$0.99C$0.67-C$0.32C$0.67C$272.05 millionC$280.03 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCARACara TherapeuticsN/AN/AN/AN/AN/AGNKGenco Shipping & Trading$1.648.04%+59.30%N/A 1 YearsMTYMTY Food GroupC$1.032.22%N/A24.24%N/ALatest SSPG, DOM, MTY, GNK, and CARA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/12/2024MTYMTY Food GroupQuarterlyC$0.282.23%5/2/20245/3/20245/15/20242/21/2024GNKGenco Shipping & TradingQuarterly$0.418.41%3/5/20243/6/20243/13/20242/2/2024MTYMTY Food GroupQuarterlyC$0.281.97%2/2/20242/15/20242/15/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCARACara TherapeuticsN/A4.544.43GNKGenco Shipping & Trading0.214.463.70MTYMTY Food Group154.980.610.57OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCARACara Therapeutics44.66%GNKGenco Shipping & Trading58.62%MTYMTY Food Group26.82%Insider OwnershipCompanyInsider OwnershipCARACara Therapeutics4.20%GNKGenco Shipping & Trading2.50%MTYMTY Food Group16.15%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCARACara Therapeutics5554.66 million52.36 millionOptionableGNKGenco Shipping & Trading1,10542.75 million41.66 millionNot OptionableMTYMTY Food Group7,32624.17 millionN/ANot OptionableSSPG, DOM, MTY, GNK, and CARA HeadlinesSourceHeadlineRenee St-Onge Buys 325 Shares of MTY Food Group Inc. (TSE:MTY) Stockmarketbeat.com - April 19 at 1:44 PMTesla Layoffs, Canadian CPI and Jamie Dimon’s Warningca.investing.com - April 18 at 7:49 PMFY2025 EPS Estimates for MTY Food Group Inc. (TSE:MTY) Boosted by National Bank Financialamericanbankingnews.com - April 18 at 3:28 AMResearch Analysts Issue Forecasts for MTY Food Group Inc.'s FY2025 Earnings (TSE:MTY)marketbeat.com - April 17 at 5:56 PMShould Investors Buy the Dip in MTY Stock?fool.ca - April 17 at 2:09 PMMTY Food Group (TSE:MTY) Given New C$55.00 Price Target at Raymond Jamesamericanbankingnews.com - April 17 at 4:22 AMMTY Food Group Inc. to Post Q2 2024 Earnings of $0.99 Per Share, Raymond James Forecasts (TSE:MTY)americanbankingnews.com - April 17 at 1:38 AMFY2024 EPS Estimates for MTY Food Group Inc. Cut by National Bank Financial (TSE:MTY)americanbankingnews.com - April 17 at 1:38 AMRaymond James Cuts MTY Food Group (TSE:MTY) Price Target to C$55.00marketbeat.com - April 16 at 11:21 AMCIBC Keeps Their Buy Rating on MTY Food Group (MTYFF)markets.businessinsider.com - April 16 at 8:09 AMNational Bank Financial Weighs in on MTY Food Group Inc.'s FY2024 Earnings (TSE:MTY)marketbeat.com - April 16 at 7:28 AMMTY Food Group (TSE:MTY) Given New C$57.00 Price Target at National Banksharesamericanbankingnews.com - April 16 at 4:22 AMMTY Food Group (TSE:MTY) Price Target Cut to C$49.00 by Analysts at TD Securitiesamericanbankingnews.com - April 16 at 3:50 AMMTY Food Group (TSE:MTY) Price Target Cut to C$53.00 by Analysts at CIBCamericanbankingnews.com - April 16 at 3:50 AMMTY Food Group (TSE:MTY) Given New C$50.00 Price Target at Scotiabankamericanbankingnews.com - April 16 at 3:50 AMMTY Food Group (TSE:MTY) Price Target Lowered to C$51.00 at Royal Bank of Canadaamericanbankingnews.com - April 16 at 3:50 AMMTY Food Group (TSE:MTY) Price Target Lowered to C$65.00 at Acumen Capitalamericanbankingnews.com - April 16 at 3:50 AMDon't Look Now But Food Courts Are In And These Brands Are Cashing Inmsn.com - April 15 at 6:09 PMMonday’s analyst upgrades and downgrades for April 15theglobeandmail.com - April 15 at 7:40 AMMTY Food Group (TSE:MTY) Posts Earnings Results, Misses Expectations By $0.12 EPSamericanbankingnews.com - April 15 at 7:08 AMMTY Food Group (TSE:MTY) Stock Price Down 7.9% After Earnings Missamericanbankingnews.com - April 14 at 1:42 AMMTY Food Group Inc. (MTYFF) Q1 2024 Earnings Call Transcriptseekingalpha.com - April 14 at 1:14 AMMTY Food Group First Quarter 2024 Earnings: EPS: CA$0.71 (vs CA$0.75 in 1Q 2023)finance.yahoo.com - April 13 at 10:13 AMMTY Food Group Inc. Plans Quarterly Dividend of $0.28 (TSE:MTY)marketbeat.com - April 13 at 8:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come3 Steel Stocks Could Soar on New China TariffsApril 18, 2024 9:15 AMView 3 Steel Stocks Could Soar on New China TariffsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookApril 19, 2024 7:06 AMView Taiwan Semiconductor Earnings: AI Dominance and Future OutlookAll Headlines Company DescriptionsCara TherapeuticsNASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.Genco Shipping & TradingNYSE:GNKGenco Shipping & Trading Limited, together with its subsidiaries, engages in the ocean transportation of drybulk cargoes worldwide. The company owns and operates dry bulk vessels to transports iron ore, grains, coal, steel products, and other drybulk cargoes. It charters its vessels primarily to trading houses, including commodities traders; producers; and government-owned entities. The company was incorporated in 2004 and is headquartered in New York, New York.MTY Food GroupTSE:MTYMTY Food Group Inc. operates and franchises quick-service, fast-casual, and casual dining restaurants in Canada, the United States, and internationally. It also sells retail products under a multitude of banners. The company was formerly known as iNsu Innovations Group Inc. and changed its name to MTY Food Group Inc. in July 2003. MTY Food Group Inc. was founded in 1979 and is headquartered in Saint-Laurent, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.